Phase I/II a clinical trial of PL265 in patients with ocular pain.

Trial Profile

Phase I/II a clinical trial of PL265 in patients with ocular pain.

Planning
Phase of Trial: Phase I/II

Latest Information Update: 12 May 2017

At a glance

  • Drugs PL 265 (Primary)
  • Indications Neuropathic pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 May 2017 This trial is expected to begin in 2018, according to a Pharmaleads media release.
    • 11 May 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top